Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

AIM: The present study investigated the link between peripheral DNA methylation (DNAm), cognitive impairment and brain aging. METHODS: We tested the association between blood genome-wide DNAm profiles using the Illumina 450K arrays, cognitive dysfunction and brain MRI measures in selected participants of the Whitehall II imaging sub-study. RESULTS: Eight differentially methylated regions were associated with cognitive impairment. Accelerated aging based on the Hannum epigenetic clock was associated with mean diffusivity and global fractional anisotropy. We also identified modules of co-methylated loci associated with white matter hyperintensities. These co-methylation modules were enriched among pathways relevant to β-amyloid processing and glutamatergic signaling. CONCLUSION: Our data support the notion that blood DNAm changes may have utility as a biomarker for cognitive dysfunction and brain aging.

Original publication

DOI

10.2217/epi-2017-0132

Type

Journal article

Journal

Epigenomics

Publication Date

05/2018

Volume

10

Pages

585 - 595

Keywords

DNA methylation, MCI, MRI, brain aging, epigenetic clock, mild cognitive impairment, peripheral biomarker, Aging, Premature, Biomarkers, Brain, Cognitive Aging, Cognitive Dysfunction, DNA, DNA Methylation, Epigenesis, Genetic, Functional Neuroimaging, Humans, Magnetic Resonance Imaging, Pilot Projects